Skip Navigation

Press Releases

How the Lungs Work News Items

Filter Press Releases

May 22, 2017

COPD National Action Plan aims to reduce the burden of the third leading cause of death

The National Heart, Lung, and Blood Institute (NHLBI), along with federal and non-federal partners, today released the first-ever COPD National Action Plan, a detailed, patient-centered roadmap for addressing one of the most urgent health concerns facing Americans. The plan was released at the American Thoracic Society International Conference meeting this week in Washington, D.C. NHLBI is part of the National Institutes of Health.

diagram showing differences between healthy airway and cystic fibrosis airway
May 20, 2012

Concentrated saline therapy not effective in young children with cystic fibrosis

Inhaling concentrated saline (salt water) mist does not reduce how often infants and young children with cystic fibrosis (CF) need antibiotics for respiratory symptoms, according to findings from a clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

October 30, 2002

NHLBI Funds Centers for Reducing Asthma Disparities

The National Heart, Lung, and Blood Institute (NHLBI) has created a new program to accelerate research aimed at understanding why certain racial, ethnic, and socioeconomic groups are more severely affected by asthma than other populations and at determining ways to close the gaps in prevalence and treatment of this common chronic disease.

September 26, 2001

NHLBI Supported Study Finds Inhaled Steroids Accelerate Bone Loss in Women with Asthma

Premenopausal women who use inhaled corticosteroids to treat persistent asthma may experience accelerated bone loss in the hip compared to those who do not use inhaled steroids, according to results of a new study of 109 women ages18 to 45 years old. In the September 27, 2001, issue of the New England Journal of Medicine (NEJM), researchers at Brigham and Women's Hospital (BWH) in Boston report that the effect of the inhaled steroids was directly related to the dose - that is, the bone density loss increased with the number of puffs per day and persisted throughout the three-year study.

August 14, 2001

NHLBI-Funded Emphysema Study Finds Certain Patients at High Risk for Death Following Lung Surgery

Emphysema patients who have severe lung obstruction with either limited ability to exchange gas when breathing or damage that is evenly distributed throughout their lungs receive little benefit from lung volume reduction surgery (LVRS) and are at high risk of death from the procedure, according to early results from the National Emphysema Treatment Trial (NETT). NETT is a five-year, multicenter, randomized study to evaluate the role of LVRS in the treatment of severe emphysema.

Page 1 of 2